服务热线
15365833739 
On April 12, 2026, the four-day 93rd China International Medical Equipment Fair (CMEF) officially concluded at the National Exhibition and Convention Center (Shanghai). As an annual vane of the global healthcare industry, this exhibition themed “Innovation Fusion, Infinite Evolution” fully demonstrated the innovative ecosystem and development trajectory of the global medical and health sector. As a high-tech enterprise deeply engaged in medical equipment R&D and manufacturing, as well as a drafting unit of national industrial standards for dual-energy X-ray bone densitometers, Pinyuan Medical showcased five core product series at the event. With solid technical accumulation, reliable product quality and professional service capabilities, the company stood out as a highlight of the exhibition, achieving fruitful results and winning wide recognition and praise from all sectors of the industry.
At this exhibition, Pinyuan Medical centrally displayed five flagship product lines, including dual-energy X-ray bone densitometers, ultrasonic bone densitometers, X-ray bone age analyzers, arteriosclerosis detectors and pulmonary function testers. All independently developed and iterated by the company, these products cover multiple clinical scenarios such as bone health screening, children’s growth and development assessment, respiratory function detection and vascular health evaluation. Featuring high accuracy, high efficiency, safety and full-scenario adaptability, the products gained high popularity and unanimous praise from professional visitors throughout the exhibition.
Among them, the three major dual-energy X-ray bone densitometer series are precisely positioned to meet differentiated needs of various medical institutions. The Dexa Pro Series focuses on comprehensive performance and clinical adaptability. Adopting the 3rd-generation cone-beam planar dual-energy X-ray technology, it delivers fast imaging and ultra-high precision, suitable for hospitals at all levels. The DXA-800 Series is equipped with a dynamic flat-panel detector and integrates dual functions of bone density testing and bone age assessment, balancing precision and efficiency perfectly for routine diagnosis and screening in large and medium-sized hospitals. As a portable bedside DXA device, the compact and lightweight DXA-500 Series adapts to physical examination centers, mobile medical services and bedside testing scenarios, and has received high recognition from osteoporosis experts.
The BMD-A series ultrasonic bone densitometers feature radiation-free, non-invasive and convenient detection. Built with multi-ethnic general clinical databases and exclusive pediatric databases, and supporting multi-language operation interfaces, the products are widely applied in medical institutions and community health service centers of all levels, realizing full-age bone health screening coverage. Their stable performance and accurate detection results have built a solid market reputation and gained long-term customer trust.
The BAD-Q series X-ray bone age analyzers are specially developed for children and adolescent growth monitoring. Featuring clear carpal bone imaging and embedded with multiple authoritative assessment algorithms including TW3 and China-05 standards, the devices assist clinicians in accurate bone age judgment and height prediction, providing reliable data support for screening growth disorders and diagnosing pediatric endocrine diseases. During the exhibition, numerous pediatric and endocrinology specialists conducted in-depth exchanges and highly affirmed its high clinical value.
In addition, the ADS-6000 series arteriosclerosis detectors adopt non-invasive detection technology, enabling rapid evaluation of limb vascular elasticity and arteriosclerosis degree without blood collection, perfectly matching the needs of physical examination centers, cardiology departments and primary chronic disease management. The LUD-V series pulmonary function testers feature simple and efficient operation, supporting rapid detection of multiple respiratory indicators. Widely used in respiratory diagnosis, routine physical examination and occupational health monitoring, they provide strong evidence for early screening and whole-course management of respiratory diseases. Guided by the medical concept of “early screening and early intervention”, both products attracted extensive attention from institutional visitors.
During the exhibition, Pinyuan Medical set up a professional service team composed of R&D engineers, clinical application specialists and sales consultants to provide one-on-one professional consulting services for all visitors. Through physical product display, on-site demonstration and interactive experience, the team elaborated on product technical principles, performance parameters, clinical application scenarios and cooperation policies. We provided full-cycle services including product selection, personalized solution design and after-sales guarantee, fully meeting diverse visitor needs and winning widespread recognition with professionalism and sincerity.
In the negotiation area, the team conducted in-depth communication with hospital directors, department heads, procurement managers and industry distributors from across the country. We accurately captured market demands and cooperation intentions, and fully interpreted our product advantages, technical strengths and market support policies, reaching multiple preliminary cooperation intentions and laying a solid foundation for subsequent market expansion and channel layout.
As a professional manufacturer specializing in the R&D, production and sales of medical health testing equipment, Pinyuan Medical has always prioritized technological innovation and quality improvement since its establishment. Participation in the 93rd CMEF serves not only as an important window to showcase our technical strength and product advantages, but also as a key platform for in-depth industry exchanges and opportunity exploration. By keeping close track of global cutting-edge medical technologies, the company has further clarified the direction of product innovation and market strategic layout.
The conclusion of the 93rd CMEF marks the end of a grand medical technology event and a new starting point for Pinyuan Medical to deepen precision medical layout and empower the upgrading of the healthcare industry. In the future, taking this exhibition as an opportunity, Pinyuan Medical will continue to focus on R&D innovation of medical devices, continuously optimize product performance and enrich the product system. Adhering to strict quality standards and improving comprehensive service capabilities, we will further deepen the domestic market and expand global layout, committed to providing more accurate, efficient and convenient medical testing solutions for medical institutions worldwide.
